Ascendis Pharma A/S (Nasdaq: ASND) today announced that it has called all $575.0 million aggregate principal amount of its outstanding 2.25% Convertible Senior Notes due 2028 (the “notes”) (CUSIP No.

Good afternoon, everyone, and thank you for joining us. Today, I'll highlight our progress in Q3 and then provide updates on our initiatives in smartphones, smart eyewear, defense and strategic ...

Mecum Indy’s Saturday docket on May 9, 2026, brings together six memorable convertibles, from a V12 Mercedes SL600 and a 1966 ...

DDC will host its Fiscal Year 2025 earnings conference call at 8:30 am Eastern Time today, April 21, 2026. A live webcast of ...

A 9,000-rpm flat-six meets open skies, yet the GT3 S/C raises questions about whether Porsche is redefining purity or quietly ...

Atlas Energy Solutions Inc. Announces Pricing of Upsized $390 Million Private Placement of 0.50% Convertible Senior Notes Due 2031 Atlas Energy Solutions Inc. (NYSE: AESI) (together with its ...

Orthocell shares have surged on the back of the nerve repair house gaining access to US military and veterans' hospitals ...

Early versions of computers, laptops, game systems, and even those old "brick" cellphones have been known to sell for ...

IREN stock price has slumped into a bear market despite the ongoing demand for artificial intelligence (AI) computing. It was ...

There is always an opportunity to give your entryway a big design moment, even if it's small, according to interior designer ...

(NASDAQ:SHAZ) and its subsidiaries ("Sharon AI" or "the Company"), a leading Australian neocloud, announced the accelerated receipt of the remaining outstanding US$50 million Senior Secured ...